These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38543235)

  • 1. Studying the API Distribution of Controlled Release Formulations Produced via Continuous Twin-Screw Wet Granulation: Influence of Matrix Former, Filler and Process Parameters.
    Denduyver P; Vervaet C; Vanhoorne V
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous twin screw granulation of controlled release formulations with various HPMC grades.
    Vanhoorne V; Janssens L; Vercruysse J; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2016 Sep; 511(2):1048-57. PubMed ID: 27521702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous twin screw granulation: A complex interplay between formulation properties, process settings and screw design.
    Portier C; Pandelaere K; Delaet U; Vigh T; Di Pretoro G; De Beer T; Vervaet C; Vanhoorne V
    Int J Pharm; 2020 Feb; 576():119004. PubMed ID: 31935475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters.
    Vanhoorne V; Vanbillemont B; Vercruysse J; De Leersnyder F; Gomes P; Beer TD; Remon JP; Vervaet C
    Int J Pharm; 2016 May; 505(1-2):61-8. PubMed ID: 27041123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous twin screw granulation: Impact of binder addition method and surfactants on granulation of a high-dosed, poorly soluble API.
    Portier C; Vigh T; Di Pretoro G; De Beer T; Vervaet C; Vanhoorne V
    Int J Pharm; 2020 Mar; 577():119068. PubMed ID: 31981703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation.
    Vanhoorne V; Bekaert B; Peeters E; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2016 Jun; 506(1-2):13-24. PubMed ID: 27094358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing API raw material variability during continuous twin-screw wet granulation.
    Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Vervaet C; De Beer T
    Int J Pharm; 2019 Apr; 561():265-273. PubMed ID: 30851387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scale-up in twin-screw wet granulation: impact of formulation properties.
    Franke M; Riedel T; Meier R; Schmidt C; Kleinebudde P
    Pharm Dev Technol; 2023 Dec; 28(10):948-961. PubMed ID: 37889884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of continuous twin-screw melt granulation mechanisms for different screw configurations, process settings and formulation.
    Van de Steene S; Van Renterghem J; Vanhoorne V; Vervaet C; Kumar A; De Beer T
    Int J Pharm; 2023 Jan; 630():122322. PubMed ID: 36448825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twin screw wet granulation: Effect of process and formulation variables on powder caking during production.
    Saleh MF; Dhenge RM; Cartwright JJ; Hounslow MJ; Salman AD
    Int J Pharm; 2015 Dec; 496(2):571-82. PubMed ID: 26536529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization and understanding of the granulation liquid mixing and distribution during continuous twin screw granulation using NIR chemical imaging.
    Vercruysse J; Toiviainen M; Fonteyne M; Helkimo N; Ketolainen J; Juuti M; Delaet U; Van Assche I; Remon JP; Vervaet C; De Beer T
    Eur J Pharm Biopharm; 2014 Apr; 86(3):383-92. PubMed ID: 24211658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous twin screw granulation: Robustness of lactose/MCC-based formulations.
    Portier C; De Vriendt C; Vigh T; Di Pretoro G; De Beer T; Vervaet C; Vanhoorne V
    Int J Pharm; 2020 Oct; 588():119756. PubMed ID: 32783981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faster to First-time-in-Human: Prediction of the liquid solid ratio for continuous wet granulation.
    Junnila A; Wikström H; Megarry A; Gholami A; Papathanasiou F; Blomberg A; Ketolainen J; Tajarobi P
    Eur J Pharm Sci; 2022 May; 172():106151. PubMed ID: 35217210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified end-to-end continuous manufacturing by feeding API suspensions in twin-screw wet granulation.
    Schmidt A; de Waard H; Moll KP; Kleinebudde P; Krumme M
    Eur J Pharm Biopharm; 2018 Dec; 133():224-231. PubMed ID: 30291963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous twin screw granulation: Influence of process and formulation variables on granule quality attributes of model formulations.
    Portier C; Pandelaere K; Delaet U; Vigh T; Kumar A; Di Pretoro G; De Beer T; Vervaet C; Vanhoorne V
    Int J Pharm; 2020 Feb; 576():118981. PubMed ID: 31935472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous twin screw granulation: Impact of microcrystalline cellulose batch-to-batch variability during granulation and drying - A QbD approach.
    Portier C; Vigh T; Di Pretoro G; Leys J; Klingeleers D; De Beer T; Vervaet C; Vanhoorne V
    Int J Pharm X; 2021 Dec; 3():100077. PubMed ID: 33870182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated twin-screw wet granulation, continuous vibrational fluid drying and milling: A fully continuous powder to granule line.
    Fülöp G; Domokos A; Galata D; Szabó E; Gyürkés M; Szabó B; Farkas A; Madarász L; Démuth B; Lendér T; Nagy T; Kovács-Kiss D; Van der Gucht F; Marosi G; Nagy ZK
    Int J Pharm; 2021 Feb; 594():120126. PubMed ID: 33321167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Assessment of Mass Flow Boundaries in Continuous Twin-screw Granulation.
    Schmidt A; de Waard H; Moll KP; Krumme M; Kleinebudde P
    Chimia (Aarau); 2016; 70(9):604-9. PubMed ID: 27646540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of formulation and process variables on lipid based sustained release tablets via continuous twin screw granulation: A comparative study.
    Kallakunta VR; Tiwari R; Sarabu S; Bandari S; Repka MA
    Eur J Pharm Sci; 2018 Aug; 121():126-138. PubMed ID: 29772273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.